2014
DOI: 10.1002/hed.23795
|View full text |Cite
|
Sign up to set email alerts
|

Study of MET protein levels andMETgene copy number in 72 sinonasal intestinal-type adenocarcinomas

Abstract: MET is overproduced in about two third of ITACs, suggesting a role for the MET signaling pathway in the oncogenesis of these tumors.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
17
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 21 publications
(20 citation statements)
references
References 43 publications
1
17
0
Order By: Relevance
“…After title and abstract checking, 36 studies remained for the further evaluating in details, in which 15 articles were excluded for there were no enough data to calculate the survival rate [13][14][15][16][17][18][19][20][21][22][23][24][25][26][27], one article was removed because of duplication [28]. So, a total of 20 publications were fulfilled the eligibility criteria [5][6][7][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45].…”
Section: Literature Searching and Study Characteristicsmentioning
confidence: 99%
“…After title and abstract checking, 36 studies remained for the further evaluating in details, in which 15 articles were excluded for there were no enough data to calculate the survival rate [13][14][15][16][17][18][19][20][21][22][23][24][25][26][27], one article was removed because of duplication [28]. So, a total of 20 publications were fulfilled the eligibility criteria [5][6][7][29][30][31][32][33][34][35][36][37][38][39][40][41][42][43][44][45].…”
Section: Literature Searching and Study Characteristicsmentioning
confidence: 99%
“…Gain of chromosome 7 (polysomy) indicates MET overproduction. One recent study shows that the MET protein was overproduced in 64% of all ITAC cases, suggesting a role for the MET signaling pathway in the ITAC tumorigenesis …”
Section: Methodsmentioning
confidence: 99%
“…In contrast to colorectal carcinomas, activating mutations in KRAS and BRAF oncogenes are rare in ITAC [ 19 , 21 – 23 ]. Overexpression of MET protein without MET gene amplification is frequent in ITAC, but not in intestinal carcinomas, and may provide opportunities for targeted therapies [ 24 ]. Loss of annexin A1 expression and diminished A2 expression has been reported in ITAC [ 25 ].…”
Section: Immunophenotype and Molecular Featuresmentioning
confidence: 99%